The company said it extended the current exploration period for block 107 to February 2027.

"It's fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted treatment option for certain people with locally advanced or secondary breast cancer who ...

Mears is "increasingly confident of delivering against market expectations for financial 2025," it added in a trading statement. A company compiled consensus for financial 2024 predicts revenue of ...

Unite expects 97% to 98% occupancy and 4% to 5% rental growth for the 2025/26 academic year, compared to 97.5% occupancy and like-for-like rental growth of 8.2% in academic year 2024/25, and compared ...

With our newsletters and social media channels.